NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $288,000 | -5.3% | 1,300 | -43.5% | 0.02% | -8.3% |
| Q1 2021 | $304,000 | -46.8% | 2,300 | -30.3% | 0.02% | -50.0% |
| Q4 2020 | $571,000 | +55.6% | 3,300 | 0.0% | 0.05% | +33.3% |
| Q3 2020 | $367,000 | +81.7% | 3,300 | +10.0% | 0.04% | +50.0% |
| Q1 2020 | $202,000 | -60.6% | 3,000 | -50.8% | 0.02% | -47.8% |
| Q4 2019 | $513,000 | -4.8% | 6,100 | -15.3% | 0.05% | -14.8% |
| Q3 2019 | $539,000 | – | 7,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |